Palvella Therapeutics PVLA Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -92.1%— | —— | —— | —— | |
| Liquidity | |||||
| Current ratio | 5.2×-2.1× | 7.3×+4.1× | 3.2×+1.2× | 2×-0.5× | |
| Leverage | |||||
| Debt-to-equity | 0×— | —— | —— | —— | |
| Per Share | |||||
| Book value per share | $2.49-91.2% | $28.13— | —— | —— | |
| Valuation | |||||
| Market capitalization | $1.24B+820% | $134.66M— | —— | —— | |
| Price / book | 44.3×+42.1× | 2.2×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Palvella Therapeutics's ratios come from?
- Every ratio is computed from Palvella Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.